Lista de obras - Marcella Barbarino - Dominio Público Uruguay

Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.

artículo científico publicado en 2017

Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors

artículo científico publicado en 2008

Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response

artículo científico publicado en 2005

EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma

artículo científico publicado en 2020

Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells.

artículo científico publicado en 2018

Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs

artículo científico publicado en 2016

Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor

artículo científico publicado en 2003

Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors

artículo científico publicado en 2012

Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine

artículo científico publicado en 2010

MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway

scientific article published on 20 October 2019

MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes

scientific article published on 11 August 2019

Nanoparticle-biomolecular corona: A new approach for the early detection of non-small-cell lung cancer

artículo científico publicado en 2018

Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90 ⬇️

artículo científico publicado el 23 de noviembre de 2011

Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold

artículo científico publicado en 2013

Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.

artículo científico publicado en 2004

Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.

artículo científico publicado en 2007

PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach

artículo científico publicado en 2020

Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.

artículo científico publicado en 2018

ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors

artículo científico publicado en 2014

Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.

artículo científico publicado en 2014

Tumour Treating Fields for mesothelioma

scientific article published on 01 January 2020

Lista de obras de Marcella Barbarino

Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients.

Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors

Development of resistance to the atypical retinoid, ST1926, in the lung carcinoma cell line H460 is associated with reduced formation of DNA strand breaks and a defective DNA damage response

EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma

Effects of antioxidants on apoptosis induced by dasatinib and nilotinib in K562 cells.

Flavopiridol: An Old Drug With New Perspectives? Implication for Development of New Drugs

Inhibition of telomerase increases resistance of melanoma cells to temozolomide, but not to temozolomide combined with poly (adp-ribose) polymerase inhibitor

Isoxazolo(aza)naphthoquinones: a new class of cytotoxic Hsp90 inhibitors

Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine

MicroRNA Mediate Visfatin and Resistin Induction of Oxidative Stress in Human Osteoarthritic Synovial Fibroblasts Via NF-κB Pathway

MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes

Nanoparticle-biomolecular corona: A new approach for the early detection of non-small-cell lung cancer

Novel 3,4-Isoxazolediamides as Potent Inhibitors of Chaperone Heat Shock Protein 90 ⬇️

Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold

Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.

Omega-alkoxy analogues of SAHA (vorinostat) as inhibitors of HDAC: a study of chain-length and stereochemical dependence.

PRMT5 silencing selectively affects MTAP-deleted mesothelioma: In vitro evidence of a novel promising approach

Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.

ST7612AA1, a thioacetate-ω(γ-lactam carboxamide) derivative selected from a novel generation of oral HDAC inhibitors

Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.

Tumour Treating Fields for mesothelioma